Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence-based treatment recommendations for uremic bleeding.

Stephanie J Hedges1, Sarah B Dehoney, Justin S Hooper

  • 1University of Mississippi Medical Center, Jackson, MS, USA.

Nature Clinical Practice. Nephrology
|February 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world experience with lecanemab therapy for Alzheimer's disease in the Intermountain West.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Tissue Plasminogen Activator Prescription and Administration Errors within a Regional Stroke System.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Comparison of chronic systolic heart failure guideline adherence for two ambulatory clinics.

Pharmacy practice·2014
Same author

A retrospective study of the lipid-lowering efficacy and safety of ezetimibe added to hydroxy methylglutaryl coenzyme A reductase therapy in HIV-infected patients with hyperlipidemia.

Journal of clinical lipidology·2011
Same author

Acute elevation of triglycerides after initiation of fosamprinavir/ritonavir in an HIV-negative patient with baseline hypertriglyceridemia.

Journal of clinical lipidology·2011
Same author

Combination thiazolidinedione and fibrate effect on high-density lipoprotein cholesterol (HDL-C) concentration in a Veterans Affairs patient population.

Journal of clinical lipidology·2011
Same journal

Awareness and outreach.

Nature clinical practice. Nephrology·2020
Same journal

Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease: shared disease mechanisms?

Nature clinical practice. Nephrology·2009
Same journal

Looking into the crystal ball: kidney transplantation in 2025.

Nature clinical practice. Nephrology·2009
Same journal

Depth of inflammation in Crohn's disease.

Nature clinical practice. Nephrology·2009
Same journal

Comment on "Home fingerprick sampling for immunosuppressant drug monitoring in pediatric renal transplant recipients".

Nature clinical practice. Nephrology·2009
Same journal

Skin problems in chronic kidney disease.

Nature clinical practice. Nephrology·2009
See all related articles

Uremic bleeding syndrome, a complication of renal failure, stems from complex factors. This review details hemostatic mechanisms and evaluates treatments like dialysis and desmopressin for managing bleeding in kidney disease patients.

Area of Science:

  • Nephrology
  • Hematology

Background:

  • Uremic bleeding syndrome is a significant complication of chronic kidney disease.
  • Its pathophysiology is multifactorial, involving disruptions in normal hemostatic and homeostatic processes.
  • Understanding these dysfunctions is crucial for effective management.

Purpose of the Study:

  • To review normal hemostatic and homeostatic mechanisms.
  • To discuss the dysfunctional components contributing to uremic bleeding.
  • To compare various treatment options for uremic bleeding syndrome.

Main Methods:

  • Literature review of normal hemostasis and uremic bleeding pathophysiology.
  • Comparative analysis of treatment modalities including dialysis, erythropoietin, cryoprecipitate, desmopressin, and conjugated estrogens.

Related Experiment Videos

  • Review of clinical trials evaluating treatment efficacy.

    • Main Results:

    • Detailed comparison of treatment mechanisms, onset, and duration of efficacy.
    • Presentation of an evidence-based treatment algorithm for clinical scenarios.
    • Answers to common questions regarding uremic bleeding management.

    Conclusions:

    • Uremic bleeding syndrome requires a multifaceted management approach.
    • Treatment selection depends on individual patient factors and clinical presentation.
    • An evidence-based algorithm can guide clinicians in optimizing patient care.